ctrl K

Price Alert

SELLAS Life Sciences Grou... (SLS)

NASDAQ: SLS · Real-Time Price · USD

1.72

-0.01 (-0.58%)

At close: Aug 19, 2025, 10:19 AM

SELLAS Life Sciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	13.99M	2.53M	17.13M	21.36M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	-184K	-152K
Other Long-Term Assets	266K	275K	399K	594K
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	2.34M	499K	330K	1.44M
Total Current Assets	16.33M	3.17M	17.76M	23.04M
Property-Plant & Equipment	925K	858K	874K	723K
Goodwill & Intangibles	1.91M	1.91M	1.91M	1.91M
Total Long-Term Assets	3.1M	3.05M	3.19M	3.23M
Total Assets	19.43M	6.22M	20.94M	26.27M
Account Payables	3.5M	5.64M	3.36M	2.14M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	544K	446K	372K	198K
Other Current Liabilities	3.15M	5.71M	9.97M	-37K
Total Current Liabilities	9.51M	13.73M	15.52M	4.98M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	4K	336K
Total Long-Term Liabilities	457K	460K	577K	946K
Total Liabilities	9.97M	14.2M	16.09M	5.93M
Total Debt	1M	906K	945K	808K
Common Stock	7K	3K	2K	2K
Retained Earnings	-248.13M	-217.24M	-179.9M	-138.6M
Comprehensive Income	n/a	n/a	n/a	n/a
Shareholders Equity	9.46M	-7.98M	4.85M	20.35M
Total Investments	n/a	n/a	-184K	-152K